The biochemical and biological functions of human papillomavirus type 16 E5 protein
- PMID: 12898324
- DOI: 10.1007/s00705-003-0111-z
The biochemical and biological functions of human papillomavirus type 16 E5 protein
Abstract
Human papillomavirus type 16 (HPV-16) E5 protein, along with the more publicized E6 and E7 proteins of this virus, has been found to be oncogenic. E5 is a highly hydrophobic membrane-bound protein of 83 amino acids associated with the Golgi apparatus, endoplasmic reticulum, and nuclear membrane in infected cells. E5 can activate epidermal growth factor receptor (EGFR) through binding to the 16 kD subunit of protein pump ATPase leading to a reduced downregulation of EGFR receptors. The activation of EGFR can initiate biochemical cascades that lead to overexpression of a variety of protooncogenes and stimulate rapid cell growth. Moreover, E5 can inhibit the expression of tumor suppressor gene p21((WafI/SdiI/CipI)) and impair the control of cell cycle checkpoint. E5 protein has been identified as a potential tumor vaccine target antigen.
Similar articles
-
The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.Virology. 1995 Aug 1;211(1):227-33. doi: 10.1006/viro.1995.1395. Virology. 1995. PMID: 7645215
-
Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.Oncogene. 2000 Aug 3;19(33):3727-32. doi: 10.1038/sj.onc.1203718. Oncogene. 2000. PMID: 10949926
-
Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.Oncogene. 1992 Jan;7(1):27-32. Oncogene. 1992. PMID: 1311063
-
Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.Biochem Pharmacol. 2010 Dec 15;80(12):1930-5. doi: 10.1016/j.bcp.2010.07.013. Epub 2010 Jul 17. Biochem Pharmacol. 2010. PMID: 20643111 Review.
-
Mechanisms of cell transformation by papillomavirus E5 proteins.Oncogene. 2001 Nov 26;20(54):7866-73. doi: 10.1038/sj.onc.1204915. Oncogene. 2001. PMID: 11753669 Review.
Cited by
-
Kaempferia parviflora Extract Inhibits STAT3 Activation and Interleukin-6 Production in HeLa Cervical Cancer Cells.Int J Mol Sci. 2019 Aug 29;20(17):4226. doi: 10.3390/ijms20174226. Int J Mol Sci. 2019. PMID: 31470515 Free PMC article.
-
HPV Vaccines: today and in the Future.J Adolesc Health. 2008 Oct;43(4 Suppl):S26-40. doi: 10.1016/j.jadohealth.2008.07.010. J Adolesc Health. 2008. PMID: 18809143 Free PMC article. Review.
-
High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.Virol J. 2010 Sep 16;7:238. doi: 10.1186/1743-422X-7-238. Virol J. 2010. PMID: 20846406 Free PMC article.
-
The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.J Virol. 2010 Oct;84(20):10619-29. doi: 10.1128/JVI.00831-10. Epub 2010 Aug 4. J Virol. 2010. PMID: 20686024 Free PMC article.
-
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).J Clin Oncol. 2017 Mar;35(7):718-726. doi: 10.1200/JCO.2016.69.1667. Epub 2017 Jan 9. J Clin Oncol. 2017. PMID: 28068178 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous